{"id":"W4403303293","doi":"10.1016/j.kint.2024.09.012","title":"Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum","year":2024,"lang":"en","type":"article","venue":"Kidney International","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Medical Research Council; National Institutes of Health; Idorsia Pharmaceuticals; Samsung; Akershus Universitetssykehus; Swedish Orphan Biovitrum; Apellis Pharmaceuticals; Omeros Corporation; Therakos; BioCryst; Alnylam Pharmaceuticals; Alexion Pharmaceuticals; Sanofi; GlaxoSmithKline; Bristol-Myers Squibb; AstraZeneca; Pfizer","keywords":"Nephrology; Medicine; Internal medicine; Haemolytic-uraemic syndrome; Intensive care medicine; Chemistry; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003340588,0.0004383522,0.000694281,0.00199436,0.0007076922,0.001314206,0.0004604595,0.0005443619,0.009161953],"category_scores_gemma":[0.01221452,0.00007970189,0.001135744,0.002598581,0.0002560735,0.0006921376,0.001838608,0.001521613,0.001521156],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001510747,"about_ca_system_score_gemma":0.002228451,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005738811,"about_ca_topic_score_gemma":0.006050739,"domain_scores_codex":[0.9955595,0.0008198933,0.0004136412,0.0002449303,0.002390819,0.0005713182],"domain_scores_gemma":[0.9908131,0.0009351022,0.002700107,0.000308067,0.003789803,0.001453816],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001313663,0.0001509664,0.3787549,0.001495276,0.000980744,0.0004793153,0.0003911171,0.001143157,0.0004554235,0.003869404,0.3754468,0.2355192],"study_design_scores_gemma":[0.0002556026,0.0005229042,0.7118958,0.001924073,0.0008923472,0.001508256,0.0006905887,0.0008835802,0.000505165,0.003741844,0.2770816,0.00009815554],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"other","genre_scores_codex":[0.3648978,0.05062276,0.01260533,0.0404804,0.009220988,0.001368915,0.240394,0.001150334,0.2792595],"genre_scores_gemma":[0.8174506,0.01486749,0.002918807,0.005415012,0.003966788,0.001144969,0.1328458,0.0002305458,0.02116],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.009161953,"threshold_uncertainty_score":0.03064978,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02127626511417251,"score_gpt":0.2802181711337426,"score_spread":0.2589419060195701,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}